Patient education in gastro-oesophageal reflux disease: A randomized controlled trial

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 12, 2007, Pages 1104-1110

  Urnes, Jorgen ^a   Farup, Per G ^a   Lydersen, Stian ^a   Petersen, Hermod ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Communication; Doctorpatient relations; Dyspepsia; Heartburn; Patient education; Patients' rights; Quality of life

Indexed keywords

RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GENERAL HEALTH QUESTIONNAIRE; HEALTH CARE; HUMAN; MALE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIMARY SCHOOL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AGED; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; NORWAY; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 36248998305     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f163dc     Document Type: Article

References (34)

1. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999; 34 (Suppl 231):20-28.
2. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-1456.
3. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet 1990; 335:205-208.
4. Sonnenberg A, Delcò F, El-Serag HB. Empirical therapy vs. diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci 1998; 43:1001-1008.
5. Glise H, Hallerback B, Wiklund I. Quality of life: a reflection of symptoms and concerns. Scand J Gastroenterol Suppl 1996; 221:14-17.
6. Agréus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002; 20:347-355.
7. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003; 17:1309-1317.
8. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990; 31:401-405.
9. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther 2000; 14:1581-1588.
10. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, healthcare-seeking behavior and risk factors. Eur J Gastroenterol Hepatol 1994; 6:917-924.
11. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39:495-498.
12. Lorig K. Patient education. A practical approach. London: Thousand Oaks; New Delhi: Sage Publications Ltd; 2001.
13. Trento M, Passera P, Borgo E, Tomalino M, Bajardi M, Cavallo F, et al. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 2004; 27:670-675.
14. Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns 2004; 52:97-105.
15. Gallefoss F. The effects of patient education in asthma and COPD (thesis). Bergen: University of Bergen Norway; 2001.
16. Núñez M, Núñez E, Yoldi C, Quintó L, Hernández MV, Muñoz-Gómez J. Health-related quality of life in rheumatoid arthritis: therapeutic education plus pharmacological treatment vs. pharmacological treatment only. Rheumatol Int 2006; 26:752-757.
17. Lorig KR, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999; 37:5-14.
18. Borgaonkar MR, Townson G, Donnelly M, Irvine EJ. Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2002; 8:264-269.
19. Shepanski MA, Hurd LB, Culton K, Markowitz JE, Mamula P, Baldassano RN. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005; 11:164-170.
20. Kennedy AP, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004; 53:1639-1645.
21. Robinson A, Lee V, Kennedy A, Middleton L, Rogers A, Thompson DG, et al. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 2006; 55:643-648.
22. Aronson BS. Applying clinical practice guidelines to a patient with complicated gastroesophageal reflux disease. Gastroenterol Nurs 2000; 23:143-147.
23. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999; 94:1434-1442.
24. Johannessen T, Petersen H, Kristensen P, Fosstvedt D, Kleveland PM, Dybdahl J, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scand J Gastroenterol 1992; 27:189-195.
25. Urnes J, Johannessen T, Farup PG, Lydersen S, Petersen H. Digestive symptoms and their psychosocial impact: validation of a questionnaire. Scand J Gastroenterol 2006; 41:1019-1027.
26. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47:81-87.
27. Jenkinson C, Fitzpatrick R. Measurement of health status in patients with chronic illness: comparison of the Nottingham health profile and the general health questionnaire. Fam Pract 1990; 7:121-124.
28. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323:1123-1124.
29. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002; 21:2917-2930.
30. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36:439-446.
31. Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol Assess 2003; 7:iii1-iii113.
32. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997; 12:38-48.
33. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA. Functional esophageal disorders. Gut 1999; 45 (Suppl 2):II31-II36.
34. Nakamura T, Shirakawa K, Masuyama H, Sugaya H, Hiraishi H, Terano A. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005; 21 (Suppl 2):19-26.